1/10/2023 8:02:59 AM
AbbVie, Anima Collaborate To Discover &develop MRNA Biology Modulators Against Oncology And Immunology Targets
1/9/2023 7:02:55 AM
AbbVie : Health Canada Approves QULIPTA For Preventive Treatment Of Episodic Migraine In Adults
1/6/2023 8:03:36 AM
AbbVie And Immunome Announce Strategic Collaboration To Discover Up To 10 Novel Antibody-target Pairs
1/6/2023 8:01:58 AM
AbbVie And Immunome Collaborate To Discover Multiple Novel Oncology Targets
12/16/2022 7:33:44 AM
AbbVie Submits SNDA To FDA To Support New Indication Of LINZESS For Functional Constipation In Children And Adolescents
12/10/2022 12:34:19 PM
AbbVie Presents CAPTIVATE And GLOW Studies At ASH Annual Meeting
12/6/2022 8:02:15 AM
AbbVie Collaborates With HotSpot Therapeutics To Further Expand Immunology Pipeline
12/1/2022 7:02:56 AM
AbbVie Announces Provincial Reimbursement For RINVOQ For Treatment Of Rheumatoid Arthritis And Psoriatic Arthritis
11/23/2022 2:01:57 AM
AbbVie : European Commission Approves SKYRIZI For Treatment Of Moderate To Severe Active Crohn's Disease